Spencer Feldman

Overview of diagnosis, stage-based treatments, side effects and follow-up to help patients with cancer understand care choices and expectations.

A three-time survivor stresses second opinions, therapy and caregiver self-care to help patients navigate treatment, recovery and life after surgery.

Heather Quintana Suchan, a nonsmoker with stage 4 lung cancer, credits genomic testing and Rybrevant and urges others not to ignore mild symptoms.

Riozzi Bodine shares how her daughter’s diagnosis inspired the launch of a foundation offering cold caps, wigs and caregiver support.

A nurse practitioner explains how FDA approval of subcutaneous Rybrevant may reduce treatment burden and improve care for patients with EGFR-mutated lung cancer.

Showing up taking notes and learning the disease can help families feel empowered as new treatments expand hope and quality of life.

FDA OKs Keytruda with paclitaxel for PD-L1 positive, platinum-resistant ovarian, fallopian tube or peritoneal cancers, improving survival and delaying growth.

In CATNON, 12 cycles after radiation extended median survival past 12 years in IDH-mutant disease while concurrent dosing showed no benefit.

Drs. Miller, Orringer and Yang explain IDH testing, treatment options, quality of life and caregiver roles for patients with IDH-mutant glioma.

Hodgkin lymphoma is a cancer of the lymphatic system, which includes lymph nodes, the spleen and immune cells that help the body fight infection.

FDA expands access to CAR-T cell therapy for patients with relapsed or refractory PCNSL.

Relacorilant plus Abraxane improved overall survival by 4.1 months without added toxicity and no biomarker testing in ROSELLA.

Dr. Joshua Sabari tells CURE that surgery, radiation and systemic therapy can affect the lungs, and he urges exercise and reporting new symptoms early.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage gastrointestinal symptoms during treatment.

After a brain cancer diagnosis, Dr. Bobby Mukkamala says becoming a patient highlighted care barriers, emotions and the need for access and support.

Dr. Obeid says genetics and ongoing monitoring guide treatment and survivorship helping patients and families plan ahead and detect recurrence earlier.

An expert explains FDA-approved Lymphir for relapsed or refractory CTCL, noting 36% response rate, manageable side effects and fast relief from itching.

Lung carcinoid tumors are rare and often slow growing. Treatment depends on stage and tumor type, with surgery common early and systemic options for advanced disease.

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.

Patients with recurrent or progressive high-grade meningioma had encouraging responses to Verzenio in a phase 2 trial.

Small cell lung cancer grows quickly. Learn how it’s diagnosed, staged and treated, and what patients can expect from therapies and side effects.

Patients should understand their cancer, treatment goals and options and record questions to support informed, productive discussions with care teams.

FDA granted breakthrough therapy designation to sofetabart mipitecan for adults with platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.

Long-term CATNON trial results show radiotherapy followed by adjuvant temozolomide extends survival in patients with newly diagnosed anaplastic glioma.

Outpatient CD19 CAR-NK plus rituximab led to complete remissions up to 15 months in patients with Waldenström Non-Hodgkin lymphoma.

Dr. Benjamin Jon Golas outlines pancreatic cancer care, including surgery, chemotherapy, radiation and emerging targeted therapies at specialized centers.

An expert explains how a DLL3 blood test may help guide Imdelltra use and set expectations for patients with small cell lung cancer.

The FDA granted orphan drug designation to LP-284 for soft tissue sarcomas, supporting development of the investigational therapy for patients with cancer.

A U.S. phase 1 trial of Alveltamig opened at UK Markey, where the first patient with small cell lung cancer was treated in late October.

Nutritional support helps malnourished patients with advanced gastric cancer maintain chemotherapy and may extend time to treatment failure.